Your browser doesn't support javascript.
loading
Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.
Haudum, Christoph Walter; Kolesnik, Ewald; Colantonio, Caterina; Mursic, Ines; Url-Michitsch, Marion; Tomaschitz, Andreas; Glantschnig, Theresa; Hutz, Barbara; Lind, Alice; Schweighofer, Natascha; Reiter, Clemens; Ablasser, Klemens; Wallner, Markus; Tripolt, Norbert Joachim; Pieske-Kraigher, Elisabeth; Madl, Tobias; Springer, Alexander; Seidel, Gerald; Wedrich, Andreas; Zirlik, Andreas; Krahn, Thomas; Stauber, Rudolf; Pieske, Burkert; Pieber, Thomas R; Verheyen, Nicolas; Obermayer-Pietsch, Barbara; Schmidt, Albrecht.
Afiliação
  • Haudum CW; Center for Biomarker Research in Medicine, Graz, Austria.
  • Kolesnik E; Department of Internal Medicine, Medical University, Graz, Austria.
  • Colantonio C; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Mursic I; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Url-Michitsch M; Department of Internal Medicine, Medical University, Graz, Austria.
  • Tomaschitz A; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Glantschnig T; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Hutz B; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Lind A; Department of Internal Medicine, Medical University, Graz, Austria.
  • Schweighofer N; Department of Internal Medicine, Medical University, Graz, Austria.
  • Reiter C; Department of Internal Medicine, Medical University, Graz, Austria.
  • Ablasser K; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Wallner M; Department of Radiology, Medizinische Universitat, Graz, Austria.
  • Tripolt NJ; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Pieske-Kraigher E; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Madl T; Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Springer A; Department of Internal Medicine, Medizinische Universitat, Graz, Austria.
  • Seidel G; Department of Internal Medicine and Cardiology, Charité University Medicine, Berlin, Germany.
  • Wedrich A; Gottfried Schatz Research Center, Medical University, Graz, Austria.
  • Zirlik A; BioTechMed, Graz, Austria.
  • Krahn T; Gottfried Schatz Research Center, Medical University, Graz, Austria.
  • Stauber R; BioTechMed, Graz, Austria.
  • Pieske B; Department of Ophthalmology, Medical University, Graz, Austria.
  • Pieber TR; Department of Ophthalmology, Medizinische Universitat, Graz, Austria.
  • Verheyen N; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Obermayer-Pietsch B; Department of Internal Medicine, Medical University, Graz, Austria.
  • Schmidt A; Department of Pharmacology and Personalised Medicine, Maastricht University, Maastricht, The Netherlands.
BMJ Open ; 12(4): e058890, 2022 04 07.
Article em En | MEDLINE | ID: mdl-35393327
ABSTRACT

PURPOSE:

Accumulating evidence points towards a close relationship between cardiovascular, endocrine and metabolic diseases. The BioPersMed Study (Biomarkers of Personalised Medicine) is a single-centre prospective observational cohort study with repetitive examination of participants in 2-year intervals. The aim is to evaluate the predictive impact of various traditional and novel biomarkers of cardiovascular, endocrine and metabolic pathways in asymptomatic individuals at risk for cardiovascular and/or metabolic disease.

PARTICIPANTS:

Between 2010 and 2016, we recruited 1022 regional individuals into the study. Subjects aged 45 years or older presenting with at least one traditional cardiovascular risk factor or manifest type 2 diabetes mellitus (T2DM) were enrolled. The mean age of the participants was 57±8 years, 55% were female, 18% had T2DM, 33% suffered from arterial hypertension, 15% were smokers, 42% had hyperlipidaemia, and only 26% were at low cardiovascular risk according to the Framingham 'Systematic COronary Risk Evaluation'. FINDINGS TO DATE Study procedures during screening and follow-up visits included a physical examination and comprehensive cardiovascular, endocrine, metabolic, ocular and laboratory workup with biobanking of blood and urine samples. The variety of assessed biomarkers allows a full phenotyping of individuals at cardiovascular and metabolic risk. Preliminary data from the cohort and relevant biomarker analyses were already used as control population for genomic studies in local and international research cooperation. FUTURE PLANS Participants will undergo comprehensive cardiovascular, endocrine and metabolic examinations for the next decades and clinical outcomes will be adjudicated prospectively.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article